Prescriber's Letter | Unbiased Medication Updates & CME

September 2023 Issue

Know What’s New for 2023-2024 Flu Immunizations

You’ll play a key role in optimizing flu vaccines for 2023-2024...

Resources

FAQ: Flu Vaccines for 2023-24

Help Patients Age 60 and Over Decide About the RSV Vaccine

We’re getting questions about the first vaccines to prevent respiratory syncytial virus (RSV) in older adults...

Be Ready to Manage Treatment-Resistant Depression

One in 3 adults with depression don’t experience significant improvement...

Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors

New bexagliflozin (Brenzavvy) will try to shake up the SGLT2 inhibitor market...

GO TO FULL ISSUE

CE & Training

SELF-STUDY CE: Complementary Therapies for Menopause

CE-IN-THE-LETTER: Prescriber Insights September 2023

LIVE CE: Emerging Recommendations Panel September 2023

GO TO CE & TRAINING ORGANIZER >

Free Clinical Resources

Beers List of Potentially Harmful Drugs

COVID-19 Treatments of Interest

Comparison of Insulins

GO TO ALL CLINICAL RESOURCES >

What is Prescriber's Letter?

Prescriber's Letter is the fastest, most trustworthy way to find out how drug therapy changes should fit into your practice, all while earning monthly CME credit. It's 100% free from financial support of the pharma industry.

Unlock More

Prescriber's Letter is one of many medication advisory, CE, and training solutions from TRC Healthcare. We support prescribers of all kinds, at all stages of their career.

If you're a training decision-maker, learn more about our:

Solutions for Group Practices
Patient Simulations to Standardize Clinical Practice